| If this is not your name, click here. | | |
| | Contact Us | Order Now | Journals | Bookstore | Register a colleague | | |
| | | ![]() New CDC Guidelines Recommend Use of Blood Tests to Diagnose TB in Certain Populations VALENCIA, Cali -- June 24, 2010 -- The Centers for Disease Control and Prevention (CDC) has issued new guidelines on the detection of Mycobacterium tuberculosis infections. In these landmark guidelines, the CDC advises that Interferon Gamma Release Assay (IGRA) blood tests are now preferred over the tuberculin skin test (TST) for diagnosing tuberculosis (TB) infection in certain populations, including people who typically do not return for the necessary reading of TST results, and those who have received Bacille Calmette-Guérin (BCG) as a vaccine or for cancer therapy. The CDC report appears in the June 25 issue of the CDC's Morbidity & Mortality Weekly Report (MMWR). Drawbacks of using TST's -- which include a higher risk for false positives, especially in people who have been BCG-vaccinated; irritating TB-extract that must be injected under the skin; and the need for a second doctor's visit -- were evaluated by the CDC and factored into their recommendations. Specific highlights from the recommendations with regards to IGRAs include: SOURCE: Ketchum Public Relations
|